Dice CEO: Energy, T...
Health Care: Drugs
Auxilium Pharmaceuticals Inc. (AUXL: NASDAQ)
$18.85 -0.25 | -1.31%
06/01/12 - 04:00 PM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -32.92M | -51.23M | -53.46M | -46.29M |
| Operating Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -11.61M | -13.94M | -2.63M | -4.67M |
| (Increase) Decrease in Inventories | -12.26M | -17.53M | -9.77M | -4.32M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 25.75M | -1.92M | 10.12M | 11.55M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | 41.37M | 11.34M | -6.02M | 75.51M |
| Other Non-Cash Items | 17.28M | 17.48M | 17.90M | 11.74M |
| Net Cash From Continuing Operations | 30.70M | -48.89M | -41.36M | 46.71M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 30.70M | -48.89M | -41.36M | 46.71M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 39.37M | 0.00 | 0.00 | 2.40M |
| Purchases of Property, Plant & Equipment | -6.64M | -11.23M | -11.42M | -11.01M |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -156.37M | 0.00 | 0.00 | -2.40M |
| Other Cash from Investing Activities | -1.90M | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -125.14M | -10.53M | -10.62M | -9.81M |
| Issuance of Debt | 0.00 | 0.00 | 30.00M | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 3.97M | 6.60M | 121.05M | 7.81M |
| Repayment of Long-Term Debt | 0.00 | 0.00 | 0.00 | -5.00K |
| Repurchase of Capital Stock | -174.00K | -928.00K | -1.06M | -759.00K |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | -30.00M | 0.00 |
| Net Cash From Financing Activities | 3.79M | 5.67M | 119.99M | 7.05M |
| Effect of Exchange Rate Changes | -21.00K | -26.00K | 25.00K | -292.00K |
| Net Change in Cash & Cash Equivalents | -90.67M | -53.77M | 68.03M | 43.65M |
Portfolios with AUXL
- Portfolio NameUser Type
- Contributor22 Biopharma Stocks With Br...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Userinsider buying
- ContributorBarron's Summary 6-26-2010
- ContributorBarron's Research Reports 9...
- UserTrader Doug
- Userkiwiloz
- UserBarron's Summary 8-09-2008
- UserEd Mahaffey Portfolio - Ble...
Latest AUXL Headlines from TheStreet
- Stocks Under $10: Healthcare Name on Sale
05.17.12 | 07:05 am - 8 Stocks Ripping Higher on Big Volume 05.11.12 | 01:05 pm
- BioSante: A Penny Stock Still Overvalued 02.16.12 | 07:02 am
- UBS: 6 Specialty Pharma Picks to Watch 01.21.12 | 07:01 am
- Stocks to Watch as Earning Season Kicks off with Alcoa 01.09.12 | 08:01 am
- 7 Stocks Rising on Huge Volume 12.08.11 | 12:12 pm
- Auxilium Pharmaceuticals Inc. (AUXL): Today's Featured Health Care Winner 11.16.11 | 05:11 pm
- Auxilium Stock Hits New 52-Week Low (AUXL) 08.08.11 | 10:08 am
- Insiders Trading MLI, AMCX, TXI, AUXL 08.04.11 | 10:08 am
- Auxilium Stock Falls On Unusually High Volume (AUXL) 08.01.11 | 03:08 pm
Press Releases for AUXL
- Auxilium Pharmaceuticals, Inc. And FCB I LLC Receive Paragraph IV Certification Notice From Watson Laboratories, Inc. For Testim® - PR Newswire 04.16.12 | 04:04 pm
- BioSpecifics Announces Partnership Between Auxilium And Actelion For XIAFLEX® In Canada, Australia, Brazil And Mexico - PR Newswire 02.23.12 | 04:02 pm
- Auxilium Pharmaceuticals, Inc. And Actelion Pharmaceuticals Ltd. Enter A Collaboration Agreement For XIAFLEX® In Canada, Australia, Brazil And Mexico - PR Newswire 02.23.12 | 01:02 am
- Auxilium Announces Appointments To Enhance Leadership Team - PR Newswire 02.06.12 | 09:02 am
- Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed In XIAFLEX® Phase Ib Cellulite Study - PR Newswire 01.26.12 | 07:01 am
- Auxilium Pharmaceuticals, Inc. Appoints Adrian Adams Chief Executive Officer And President - PR Newswire 12.08.11 | 07:12 am
- Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed In XIAFLEX® Study For Frozen Shoulder Syndrome - PR Newswire 12.01.11 | 07:12 am
- Auxilium Pharmaceuticals To Present At The Oppenheimer 22nd Annual Healthcare Conference - PR Newswire 11.28.11 | 07:11 am
- TRiUS Data Suggests That Testim® Significantly Improved Sexual Function In Hypogonadal Men - PR Newswire 11.03.11 | 07:11 am
- Auxilium Pharmaceuticals Announces Hypogonadism Awareness Ad Campaign Wins Medical Marketing & Media Award - PR Newswire 10.13.11 | 07:10 am
Partner Headlines for AUXL
- Healthcare Biz Recap: Express Scripts New Driver, Elan Pops - Wall St. Cheat Sheet 05.27.12 | 12:05 pm
- Auxilium-Glaxo to Drive Testim Sales - Analyst Blog - Zacks 05.22.12 | 10:05 am
- Loss Narrows at Auxilium - Analyst Blog - Zacks 05.14.12 | 10:05 am
- Auxilium Misses 4Q Estimates - Analyst Blog - Zacks 02.27.12 | 10:02 am
- 10 Overvalued Healthcare Stocks - Seeking Alpha 10.25.11 | 08:10 am
- Auxilium Outlines Xiaflex Plans - Analyst Blog - Zacks 09.02.11 | 05:09 pm
- AUXL Cuts View Despite Lower Loss - Analyst Blog - Zacks 08.09.11 | 06:08 pm
- Friday Options Recap - Seeking Alpha 06.24.11 | 04:06 pm
- Strong YTD Insider Buying at These Billion Dollar Companies - Seeking Alpha 06.10.11 | 07:06 am
- Contrarian Ideas: 25 High Growth Stocks With Significant Short Selling - Seeking Alpha 06.06.11 | 08:06 am
